MiR-363-3p Induces Tamoxifen Resistance in Breast Cancer Cells Through PTEN Modulation

Overview

Journal Sci Rep

Specialty Science

Date 2024 Dec 31

PMID 39738797

Authors

Yaning Liang

Cuiyu Shi

Yu Wang

Bingjie Fan

Wei Song

Rong Shen

Affiliations

Soon will be listed here.

Abstract

Nowadays, the investigation for overcoming tamoxifen (TAM) resistance is confronting a considerable challenge. Therefore, immediate attention is required to elucidate the mechanism underlying TAM resistance in breast cancer. This research primarily aimed to define how miRNA-363-3p facilitates resistance to TAM in breast cancer. High-throughput miRNA sequencing was performed using RNAs prepared from breast cancer MCF-7 cells and TAM-resistant MCF-7 cells (MCF-7-TAM). An increase in miRNA-363-3p levels was observed in MCF-7-TAM cells. In MCF-7 cells, miRNA-363-3p directly targeted and negatively regulated phosphatase and tensin homolog (PTEN). Reduction of miRNA-363-3p retarded cell growth and accelerated cell apoptosis, thereby enhancing the sensitivity of TAM. Moreover, analysis using the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway showed significant enrichment of target genes within the phosphoinositide-3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Ultimately, miR-363-3p decreased the responsiveness of breast cancer cells to TAM by targeting and suppressing PTEN through a mechanism associated with the PI3K-Akt pathway. Therefore, these results suggest that miR-363-3p-dependent PTEN expression contributes to the mechanisms underlying breast cancer endocrine resistance.

Citing Articles

Self-control moderates the impacts of physical activity on the sleep quality of university students.

Yin Z, Yang C, Yu X Sci Rep. 2025; 15(1):4040.

PMID: 39900789 PMC: 11791187. DOI: 10.1038/s41598-025-88700-2.

References

Liu Y, Li M, Yu H, Piao H . lncRNA CYTOR promotes tamoxifen resistance in breast cancer cells via sponging miR‑125a‑5p. Int J Mol Med. 2020; 45(2):497-509. PMC: 6984795. DOI: 10.3892/ijmm.2019.4428. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Bi Y, Mao Y, Su Z, Du J, Ye L, Xu F . Long noncoding RNA HNF1A-AS1 regulates proliferation and apoptosis of glioma through activation of the JNK signaling pathway via miR-363-3p/MAP2K4. J Cell Physiol. 2020; 236(2):1068-1082. DOI: 10.1002/jcp.29916. View

Hakeem A, El-Kersh D, Hammam O, Elhosseiny A, Zaki A, Kamel K . Piperine enhances doxorubicin sensitivity in triple-negative breast cancer by targeting the PI3K/Akt/mTOR pathway and cancer stem cells. Sci Rep. 2024; 14(1):18181. PMC: 11303729. DOI: 10.1038/s41598-024-65508-0. View

Brunner N, Frandsen T, Holst-Hansen C, Bei M, Thompson E, Wakeling A . MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780. Cancer Res. 1993; 53(14):3229-32. View

Soni M, Saatci O, Gupta G, Patel Y, Raja M, Li J . miR-489 Confines Uncontrolled Estrogen Signaling through a Negative Feedback Mechanism and Regulates Tamoxifen Resistance in Breast Cancer. Int J Mol Sci. 2022; 23(15). PMC: 9331933. DOI: 10.3390/ijms23158086. View

Li A, Qiu M, Zhou H, Wang T, Guo W . PTEN, Insulin Resistance and Cancer. Curr Pharm Des. 2017; 23(25):3667-3676. DOI: 10.2174/1381612823666170704124611. View

He M, Jin Q, Chen C, Liu Y, Ye X, Jiang Y . The miR-186-3p/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells. Oncogene. 2019; 38(28):5551-5565. DOI: 10.1038/s41388-019-0817-3. View

Rong H, Chen B, Wei X, Peng J, Ma K, Duan S . Long non-coding RNA XIST expedites lung adenocarcinoma progression through upregulating MDM2 expression via binding to miR-363-3p. Thorac Cancer. 2020; 11(3):659-671. PMC: 7049521. DOI: 10.1111/1759-7714.13310. View

10.

Anastasiadi Z, Lianos G, Ignatiadou E, Harissis H, Mitsis M . Breast cancer in young women: an overview. Updates Surg. 2017; 69(3):313-317. DOI: 10.1007/s13304-017-0424-1. View

11.

Jiang H, Cheng L, Hu P, Liu R . MicroRNA‑663b mediates TAM resistance in breast cancer by modulating TP73 expression. Mol Med Rep. 2018; 18(1):1120-1126. DOI: 10.3892/mmr.2018.9064. View

12.

Taha M, Yousef E, Badr A, Salama R, Maurice N . Expression profile and functional analysis of miR-301b in patients with breast cancer: A bioinformatics, biochemical, and histopathological study. Pathol Res Pract. 2024; 262:155536. DOI: 10.1016/j.prp.2024.155536. View

13.

Shen R, Wang Y, Wang C, Yin M, Liu H, Chen J . MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer. Am J Transl Res. 2015; 7(10):2115-26. PMC: 4656789. View

14.

DiNitto J, Cronin T, Lambright D . Membrane recognition and targeting by lipid-binding domains. Sci STKE. 2003; 2003(213):re16. DOI: 10.1126/stke.2132003re16. View

15.

Drobna M, Szarzynska B, Jaksik R, Sedek L, Kuchmiy A, Taghon T . hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of and Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro. Cells. 2020; 9(5). PMC: 7290785. DOI: 10.3390/cells9051137. View

16.

Stiles B, Gilman V, Khanzenzon N, Lesche R, Li A, Qiao R . Essential role of AKT-1/protein kinase B alpha in PTEN-controlled tumorigenesis. Mol Cell Biol. 2002; 22(11):3842-51. PMC: 133830. DOI: 10.1128/MCB.22.11.3842-3851.2002. View

17.

Ikeda K, Horie-Inoue K, Ueno T, Suzuki T, Sato W, Shigekawa T . miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A. Sci Rep. 2015; 5:13170. PMC: 4530347. DOI: 10.1038/srep13170. View

18.

Chang J, Gao F, Chu H, Lou L, Wang H, Chen Y . miR-363-3p inhibits migration, invasion, and epithelial-mesenchymal transition by targeting NEDD9 and SOX4 in non-small-cell lung cancer. J Cell Physiol. 2019; 235(2):1808-1820. DOI: 10.1002/jcp.29099. View

19.

Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi M, Moradi-Kalbolandi S . Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020; 84:106535. DOI: 10.1016/j.intimp.2020.106535. View

20.

Downes C, Ross S, Maccario H, Perera N, Davidson L, Leslie N . Stimulation of PI 3-kinase signaling via inhibition of the tumor suppressor phosphatase, PTEN. Adv Enzyme Regul. 2007; 47:184-94. DOI: 10.1016/j.advenzreg.2006.12.018. View